Home » Topics » BioWorld Science

BioWorld Science
RSS

NMPA accepts IND for Simcere's anti-TNFR2 antibody SIM-0235

Oct. 18, 2021

Dual MEK inhibitor IMM-1-104 may be an improvement over approved MEK inhibitors

Oct. 18, 2021

A phosphatidylserine-containing nanoparticle platform for oral prophylactic reverse vaccination

Oct. 18, 2021

PRT-2527 shows efficacy in models of hematological and solid tumors with MYC dysregulation

Oct. 18, 2021

Farsight Medical Technology synthesizes PPIA and PPIF inhibitors

Oct. 18, 2021

AstraZeneca synthesizes new cannabinoid CB1 receptor antagonists

Oct. 18, 2021

VX-01, a humanized antibody with protective effects against murine mucormycosis

Oct. 18, 2021

Gritscience Biopharmaceuticals identifies casein kinase 1 isoform delta inhibitors

Oct. 18, 2021

Immunome details activity of anti-IL-38 monoclonal antibody IMM-20324

Oct. 18, 2021

Roche discloses new compounds for E. coli infections

Oct. 18, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...